Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retinal Thickness as a Potential Biomarker of Neurodegeneration and Early Cognitive Impairment in Patients With Multiple Sclerosis

NCT04153773 is registered in ClinicalTrials.gov with Mansoura University Hospital as lead sponsor.

NCT NCT04153773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04153773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retinal Thickness as a Potential Biomarker of Neurodegeneration and Early Cognitive Impairment in Patients With Multiple Sclerosis
Lead sponsor
Mansoura University Hospital
Phase
Observational
Overall status
Completed
Start date
August 1, 2018
Completion date
September 1, 2019
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis